Dr. John Hsu’s Agenda for the 2026 Opioid & Fentanyl Abuse Management Congress
February 23–24, 2026 • Loews Vanderbilt Hotel • Nashville, TN
Day One – Monday, February 23, 2026
7:15 Conference Registration & Networking Breakfast
8:15 Chairperson’s Opening Remarks
Adila Nathu, MD, PhD
Director, Clinical Pathology
Medical/Clinical Director, ADSCIS Laboratory
Waterford Medical Clinic
Internet Wi-Fi
Network: WCF2026!
Password: WCF20261
Presentations:
wcforum.com/182
8:30 Management of Chronic Pain in Light of the Opioid Guideline
Paul Sloan, MD
Professor of Anesthesiology
Anesthesiology, Pain Medicine, Palliative Medicine
Division Chief, Regional Anesthesia & Acute Pain Service
University of Kentucky HealthCare
9:15 Efforts to Combat the Opioid & Fentanyl Epidemic
Martin Redd
Diversion Program Manager, Louisville & Detroit Field Divisions
Drug Enforcement Administration
10:00 Networking Break & Refreshments
10:30 Medication for Opioid Use Disorder in Older Adults With Fentanyl Use: A Case Report and Clinical Insights
Bixby Ponteri, MD
Addiction Medicine Leader
BronxCare Health System
11:15 Implications of Polydrug Use and Opioid Mortality Research for Substance Use Treatment Engagement
Emmanuel Amoako, MSW, PhD Candidate
Implementation Manager, Health Lab
University of Chicago Urban Labs
12:15 Luncheon for All Attendees & Speakers
1:30 Enhancing Provider and Patient Collaboration Strategies for Effective Opioid & Fentanyl Management
Ghazala Nathu, MD, MS, PhD, FACB
Director, Clinical Pathology
Director, Point of Care
ADSCIS Laboratory / Clinical Pathology
Director, Cannabinoids / Addiction Medicine
Waterford Medical Clinic
3:00 Networking Break & Refreshments
3:30 Enhancing Community Outreach Strategies Targeting Vulnerable Populations to Provide Access to Opioid & Fentanyl Abuse Treatment
Adila Nathu, MD, PhD
Director, Clinical Pathology
Medical/Clinical Director, ADSCIS Laboratory
Waterford Medical Clinic
4:15 Hospital/Healthcare Facility Controlled Substance Diversion: Recent Case Studies
Larry Houck
Director
Hyman, Phelps & McNamara
Former Diversion Investigator
Drug Enforcement Administration
5:00 End of Day One
Day Two – Tuesday, February 24, 2026
7:15 Networking Breakfast
8:15 Chairperson’s Recap of Day One
Adila Nathu, MD, PhD
Director, Clinical Pathology
Medical/Clinical Director, ADSCIS Laboratory
Waterford Medical Clinic
8:30 Human Factor in Treating Pain and Opioid Use Disorder
John Hsu, MD
Chief Executive Officer
iPill
9:15 The Misuse of Opioids and Psychedelics: What’s Coming Next
Richard Dart, MD, PhD
Director, Rocky Mountain Poison & Drug Safety
Denver Health
10:00 Networking Break & Refreshments
10:30 Precision Medicine Technologies to Address Opioid & Fentanyl Abuse
Brian Meshkin
Executive Chairman
Proove Genomics, Inc.
Executive Chairman
Outcomeus, Inc.
11:30 Conference Concludes
If you’d like, I can also:
- Format this into a clean press-ready version
- Extract just Dr. Hsu’s speaking segment
- Turn it into a LinkedIn announcement
- Or create a branded iPill summary version
Just let me know what you need next.
